OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Publication Speed (median values for papers published in 2022): Submission to First Decision: 6 weeks; Submission to Acceptance: 14 weeks; Acceptance to Publication: 8 days (1-2 days of FREE language polishing included)
Novel Therapeutics, Techniques and Tools for Treatment of Glaucomatous Optic Neuropathy
Submission Deadline: November 30, 2023 (Open) Submit Now
Najam Sharif, PhD, DSc, FARVO, FBPhS, FAOPT
Global Alliance and External Research, Santen Inc., Emeryville, CA 94608, USA.
Adjunct Professor, University of North Texas (USA), Duke-NUS Medical School (Singapore).
Research interests: neurological diseases; therapeutics; retina and brain connections; glaucomatous optic neuropathy; optic nerve; pharmacology; drug discovery.
Shahid Husain, PhD, Professor
Department of Ophthalmology, Medical University of South Carolina, Charleston, SC 29425, USA.
Saima Chaudhry of Santen Inc. USA.
Research interests: glaucoma neuroprotection; neuroinflammation; ocular Immunology and pharmacology
Manuscript Submission Information
Manuscripts should be submitted online at http://www.lidsen.com/Passport/Index/login by registering and logging in to this website. Once registered and activated, please click here to go to the submission form. A guide for authors and other relevant information for submission of manuscripts is available on Instructions for Authors.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are highly invited. For planned papers, a tentative title and short abstract (about 100 words) can be sent to the Editorial Office (firstname.lastname@example.org) for record. Welcome your submission!
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.